← Back to Search

Health Information Technology for COVID-19 Testing

Phase 3
Waitlist Available
Led By Yelena Wu, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 3 months, 6 months, 12 months
Awards & highlights

Study Summary

This trial will help figure out how best to use technology to remind students & staff to get coronavirus tests, & will offer in-home serial testing if needed.

Who is the study for?
This trial is for school staff, parents who are legal guardians of a student and have a working cell phone, and students attending participating schools in Utah. There are no specific exclusion criteria mentioned.Check my eligibility
What is being tested?
The trial tests two methods to increase COVID-19 testing in schools: automated text messages (TM) alone or combined with follow-up from a health navigator (HN). It also offers at-home testing if in-person testing is difficult.See study design
What are the potential side effects?
Since the interventions involve information technology approaches like text messaging and health navigation, there aren't direct medical side effects. However, privacy concerns or stress related to frequent communication about COVID-19 could be potential issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 3 months, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 3 months, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Testing Uptake
Secondary outcome measures
Change in Missed School Days
Intervention Acceptability assessed using Acceptability of Intervention Measures (AIM)
Intervention Appropriateness assessed using Intervention Appropriateness Measure (IAM)
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Text Messaging + Health Navigator (TM + HN)Experimental Treatment1 Intervention
This arm consists of continued text messages (TM) about COVID-19 testing options with the addition of a brief telephone call from a health navigator (HN). These calls will be conducted using Motivation and Problem Solving (MAPS). MAPS is an empirically validated proactive coaching approach used to address barriers and motivate participants to utilize testing options if they are experiencing COVID-19 symptoms or have been exposed to someone that has tested positive for COVID-19.
Group II: Text Messaging (TM)Experimental Treatment1 Intervention
This arm consists of a text message (TM) prompt asking if a participant has COVID-19 symptoms or if a participant has been exposed to a person who has tested positive for COVID-19. If a participant responds yes, they will receive a TM prompt for immediate testing and to re-test. Participants will be provided with information on testing options. After 24 hours, the participant will receive another TM that asks if they tested and what their results are. After 3 days, participants will be prompted to re-test.
Group III: Usual CareActive Control1 Intervention
Participants will only receive public service announcement-type messaging on COVID-19 testing every 3 weeks such as recommendation to obtain COVID-19 testing if exposed or experience symptoms and information on testing options through the school or district.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,758,722 Total Patients Enrolled
14 Trials studying COVID-19
460,646 Patients Enrolled for COVID-19
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,964 Previous Clinical Trials
2,654,730 Total Patients Enrolled
12 Trials studying COVID-19
43,586 Patients Enrolled for COVID-19
Yelena Wu, PhDPrincipal InvestigatorUniversity of Utah
5 Previous Clinical Trials
11,614 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the risks associated with patients using Text Messaging + Health Navigation (TM+HN)?

"There is prior clinical data supporting the safety of Text Messaging + Health Navigation (TM+HN), so it received a score of 3."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)
Yelena Wu 2022. "Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05112900.
All > Covid 19 > Coronavirus
~6154 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top